View Older Stories

Feb 13, 2026 07:02AM AstraZeneca BREZTRI shows lung function improvements in asthma trials

Feb 11, 2026 09:01AM AstraZeneca awards $3.4 million to nonprofits for health equity programs

Feb 10, 2026 07:05AM AstraZeneca (AZN) Reports Q4 EPS of $2.12; offers guidance

Feb 10, 2026 04:52AM AstraZeneca forecasts 2026 sales, profit growth as Q4 meets expectations; stock up

Feb 9, 2026 12:00PM AstraZeneca is set to report on Tuesday. Here's what to watch out for.

Feb 3, 2026 07:00AM FDA grants Priority Review to DATROWAY for metastatic triple-negative breast cancer

Feb 3, 2026 04:11AM FDA grants Priority Review to DATROWAY for metastatic breast cancer

Feb 2, 2026 07:01AM AstraZeneca starts trading on NYSE under harmonized global structure

Jan 30, 2026 07:11AM AstraZeneca partners with CSPC on weight management drugs for $1.2B

Jan 29, 2026 05:40AM AstraZeneca plans $15 billion China investment through 2030

Jan 27, 2026 10:52AM Citi initiates coverage of European pharma stocks; AstraZeneca 'best in class'

Jan 20, 2026 06:19AM AstraZeneca to move listing from NASDAQ to NYSE in January

Jan 14, 2026 01:11AM Guggenheim Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)

Jan 13, 2026 02:50PM AstraZeneca acquires Modella AI to expand oncology AI capabilities

Jan 12, 2026 04:09AM Walmart to join Nasdaq-100 Index effective January 20

Jan 8, 2026 07:01AM AstraZeneca names Rick R. Suarez as US president and biopharmaceuticals head

Jan 6, 2026 04:36AM AstraZeneca's Saphnelo shows positive results in lupus trial

Jan 5, 2026 04:09AM BBVA USA (BBVA) and Haleon (HLN) Added to Goldman's European Conviction List Director's Cut for January 2026

Dec 22, 2025 07:01AM ENHERTU receives breakthrough designation for early breast cancer treatment

Dec 22, 2025 05:40AM AstraZeneca's (AZN) ENHERTU receives breakthrough therapy designation for early breast cancer

Dec 19, 2025 02:21PM Trump to announce prescription drug price agreements

Dec 19, 2025 08:51AM White House: Trump on Friday to announce more 'deals that will lower prices of drugs and pharmaceuticals'

Dec 18, 2025 04:41AM EMA validates application for DATROWAY as first-line treatment for TNBC

Dec 15, 2025 04:29PM ENHERTU plus pertuzumab wins FDA approval for HER2-positive breast cancer

Dec 15, 2025 02:30PM ENHERTU plus pertuzumab approved for first-line HER2+ metastatic breast cancer

Dec 9, 2025 09:58AM AstraZeneca (AZN) PT Raised to $105 at TD Cowen

Dec 9, 2025 09:28AM FDA launches fresh safety scrutiny of approved RSV therapies for infants - Reuters

Dec 4, 2025 04:00PM AstraZeneca selects Salesforce Agentforce for global customer engagement

Dec 4, 2025 07:02AM AstraZeneca presents largest-ever ASH presence with new blood cancer data

Dec 3, 2025 02:59AM AstraZeneca (AZN:LN) (AZN) PT Raised to GBP155 at Morgan Stanley

Dec 1, 2025 07:16AM Shares of vaccine makers drop after FDA memo flags reports of child deaths

Dec 1, 2025 06:53AM UK and US poised to agree zero-tariffs deal on pharmaceuticals - The Times

Nov 26, 2025 08:00AM This pharma stock is BofA's Top Pick going into 2026

Nov 26, 2025 07:01AM AstraZeneca wins FDA approval for IMFINZI as first perioperative immunotherapy for early gastric cancers

Nov 26, 2025 06:36AM Bernstein on IRA pricing: $245 really is the floor

Nov 25, 2025 01:33PM AstraZeneca's Imfinzi gets FDA approval for early gastric cancer treatment

Nov 25, 2025 05:04AM AstraZeneca (AZN) PT Raised to $108.50 at BofA Securities

Nov 21, 2025 02:05PM AstraZeneca announces $2 billion Maryland manufacturing expansion

Nov 10, 2025 04:36AM AstraZeneca (AZN) PT Raised to $87 at Leerink Partners

Nov 10, 2025 02:31AM baxdrostat shows significant blood pressure reduction in resistant hypertension trial

Nov 7, 2025 09:01AM AstraZeneca's FASENRA shows positive results in rare blood disorder trial

Nov 6, 2025 07:02AM Axsome Therapeutics acquires epilepsy drug candidate from AstraZeneca

Nov 6, 2025 05:58AM AstraZeneca (AZN) Tops Q3 EPS by 122c; offers guidance

Nov 6, 2025 12:00AM AstraZeneca earnings preview Q3: stronger print expected, focus on US prices, pipeline

Nov 5, 2025 01:08PM Trump announcement on weight loss drugs scheduled for 11 A.M. Thursday; price to drop under $150/mo - CBS

Nov 5, 2025 10:43AM AstraZeneca (AZN) call put ratio 2.1 calls to 1 put into quarter results

Oct 30, 2025 12:33PM AstraZeneca's gefurulimab meets primary endpoint in myasthenia gravis trial

Oct 29, 2025 02:04PM AstraZeneca's Alexion to present gefurulimab trial data at neurology meetings

Oct 28, 2025 04:33AM Koselugo wins EU approval for adult neurofibromatosis type 1 tumors

Oct 27, 2025 02:42AM Jefferies Upgrades AstraZeneca (AZN:LN) (AZN) to Buy

View Older Stories